OM:CHRO

Stock Analysis Report

Executive Summary

ChromoGenics AB provides glass products that control heat and light transmission in Sweden.


Snowflake Analysis

Mediocre balance sheet and overvalued.


Similar Companies

Share Price & News

How has ChromoGenics's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CHRO's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-20.9%

CHRO

10.6%

SE Building

7.4%

SE Market


1 Year Return

-75.2%

CHRO

-0.8%

SE Building

-8.2%

SE Market

Return vs Industry: CHRO underperformed the Swedish Building industry which returned -5.6% over the past year.

Return vs Market: CHRO underperformed the Swedish Market which returned -9.7% over the past year.


Shareholder returns

CHROIndustryMarket
7 Day-20.9%10.6%7.4%
30 Day-40.6%-13.0%-14.3%
90 Day-65.5%-15.6%-19.4%
1 Year-62.2%-75.2%0.8%-0.8%-5.5%-8.2%
3 Year-95.4%-97.8%20.2%13.6%4.9%-10.6%
5 Yearn/a34.3%23.2%11.9%-11.6%

Price Volatility Vs. Market

How volatile is ChromoGenics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is ChromoGenics undervalued compared to its fair value and its price relative to the market?

1.49x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate CHRO's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate CHRO's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: CHRO is unprofitable, so we can't compare its PE Ratio to the Building industry average.

PE vs Market: CHRO is unprofitable, so we can't compare its PE Ratio to the Swedish market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CHRO's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CHRO is good value based on its PB Ratio (1.5x) compared to the SE Building industry average (2.1x).


Next Steps

Future Growth

How is ChromoGenics forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

6.8%

Forecasted Capital Goods industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ChromoGenics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has ChromoGenics performed over the past 5 years?

-16.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CHRO is currently unprofitable.

Growing Profit Margin: CHRO is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CHRO is unprofitable, and losses have increased over the past 5 years at a rate of -16% per year.

Accelerating Growth: Unable to compare CHRO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CHRO is unprofitable, making it difficult to compare its past year earnings growth to the Building industry (11.3%).


Return on Equity

High ROE: CHRO has a negative Return on Equity (-182.73%), as it is currently unprofitable.


Next Steps

Financial Health

How is ChromoGenics's financial position?


Financial Position Analysis

Short Term Liabilities: CHRO's short term assets (SEK50.0M) exceed its short term liabilities (SEK41.7M).

Long Term Liabilities: CHRO's short term assets (SEK50.0M) exceed its long term liabilities (SEK47.8M).


Debt to Equity History and Analysis

Debt Level: CHRO's debt to equity ratio (116.4%) is considered high.

Reducing Debt: CHRO's debt to equity ratio has reduced from 538.7% to 116.4% over the past 5 years.


Balance Sheet

Inventory Level: CHRO has a high level of physical assets or inventory.

Debt Coverage by Assets: CHRO's debt is covered by short term assets (assets are 1x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CHRO has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CHRO has less than a year of cash runway if free cash flow continues to reduce at historical rates of -26.7% each year


Next Steps

Dividend

What is ChromoGenics's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CHRO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate CHRO's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CHRO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CHRO's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CHRO's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.8yrs

Average management tenure


CEO

Jerker Lundgren (55yo)

1.83s

Tenure

Mr. Jerker Lundgren was Founder and Chief Executive Officer of Skandinaviska Glassystem AB since 1994. Mr. Lundgren has 20+ years of experience within the construction and glass industry, including project ...


Leadership Team

NamePositionTenureCompensationOwnership
Jerker Lundgren
CEO & Director1.83yrsno datano data
Greger Gregard
Co-Founder & CTOno datano datano data
Lars Ericsson
CFO & Head of Communications1.17yrsno datano data
Micael Hamberg
Chief Operating Officer3.25yrsno data0.44% SEK281.5k

1.8yrs

Average Tenure

56yo

Average Age

Experienced Management: CHRO's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Jerker Lundgren
CEO & Director1.83yrsno datano data
Johan Hedin
Chairman of the Board0.83yrno datano data
Mari Broman
Director2.83yrsno datano data
Anders Brännström
Directorno datakr133.00k1.08% SEK684.1k
Claes-Göran Granqvist
Director17yrskr180.00kno data
Peter Gustafson
Director2.83yrsno datano data
Peter Edelsvärd
Director0.83yrno datano data

2.8yrs

Average Tenure

59yo

Average Age

Experienced Board: CHRO's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CHRO insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 472.2%.


Top Shareholders

Company Information

ChromoGenics AB's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ChromoGenics AB
  • Ticker: CHRO
  • Exchange: OM
  • Founded: 2003
  • Industry: Building Products
  • Sector: Capital Goods
  • Market Cap: kr63.375m
  • Shares outstanding: 402.38m
  • Website: https://www.chromogenics.com

Number of Employees


Location

  • ChromoGenics AB
  • Ullforsgatan 15
  • Uppsala
  • Uppsala County
  • 752 28
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CHROOM (OMX Nordic Exchange Stockholm)YesCommon StockSESEKMar 2017
384DB (Deutsche Boerse AG)YesCommon StockDEEURMar 2017
CHRO BTAOM (OMX Nordic Exchange Stockholm)NPV BTA 052020SESEKMar 2020

Biography

ChromoGenics AB provides glass products that control heat and light transmission in Sweden. It offers dynamic and static glasses, and colored solar facades. It markets its products under the ConverLight name. The company was founded in 2003 and is headquartered in Uppsala, Sweden. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/03/31 00:35
End of Day Share Price2020/03/30 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.